A Study of Temodar With PCI-24781 for Patients With Recurrent Glioma
Conditions: Recurrent High Grade Glioma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Glioblastoma; Gliosarcoma Interventions: Drug: PCI 24781; Drug: Temozolomide Sponsors: University of Nebraska; Xynomic Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials